feed,title,long_url,short_url
SeekingAlpha,Reviva reports FDA acceptance of 4-week RECOVER-2 study for its schizophrenia treatment,https://seekingalpha.com/news/4089606,
SeekingAlpha,Citigroup sees Coupang subscription price hike as 'highly profitable',https://seekingalpha.com/news/4089604,
SeekingAlpha,IperionX to supply titanium products to United Stars,https://seekingalpha.com/news/4089599,
SeekingAlpha,"Extreme Networks gains as B. Riley upgrades amid inventory, demand improvements",https://seekingalpha.com/news/4089595,
